Qiagen N.V.
QGEN- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001015820
No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Qiagen N.V. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 289
- −1 vs. Q1 2022
- Shares held
- 129.9M
- +776.9K (+0.6%) vs. Q1 2022
- Total value
- $6.11B
- −$232.4M (−3.7%) vs. Q1 2022
- New holders
- 31
- 111 more added
- Sold out
- 32
- 95 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 337 | $5.68B |
| Q1 2026 | 346 | $5.02B |
| Q4 2025 | 322 | $6.77B |
| Q3 2025 | 339 | $6.84B |
| Q2 2025 | 318 | $7.23B |
| Q1 2025 | 300 | $5.92B |
| Q4 2024 | 325 | $6.60B |
| Q3 2024 | 330 | $7.05B |
| Q2 2024 | 305 | $6.22B |
| Q1 2024 | 282 | $5.83B |
| Q4 2023 | 278 | $6.09B |
| Q3 2023 | 279 | $5.40B |
| Q2 2023 | 283 | $6.14B |
| Q1 2023 | 288 | $6.23B |
| Q4 2022 | 300 | $6.76B |
| Q3 2022 | 297 | $5.73B |
| Q2 2022 | 289 | $6.11B |
| Q1 2022 | 294 | $6.39B |
| Q4 2021 | 302 | $7.40B |
| Q3 2021 | 267 | $6.77B |
| Q2 2021 | 259 | $5.98B |
| Q1 2021 | 276 | $5.97B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Qiagen N.V.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sciencast Management LP | 0 | $0 | 0.00% | −7,054−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −6,522−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −5,405−100.0% | Sold out |
| SkyView Investment Advisors, LLC | 0 | $0 | 0.00% | −5,331−100.0% | Sold out |
| KB Financial Partners, LLC | 0 | $0 | 0.00% | −4,999−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −4,984−100.0% | Sold out |
| Veriti Management LLC | 0 | $0 | 0.00% | −4,580−100.0% | Sold out |
| Clarius Group, LLC | 0 | $0 | 0.00% | −3,868−100.0% | Sold out |
| Balentine LLC | 0 | $0 | 0.00% | −4,255−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −401−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −367−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −208−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| JJJ Advisors Inc. | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Dixon Hughes Goodman Wealth Advisors LLC | – | – | – | – | Not filed |